 |
 |

COMMENTS AND OPINIONS
Vitamin D Level, Respiratory Tract Infections, and Controlled Trials
Harri Hemilä, PhD, MD
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Proponents of evidence-based medicine argue that conclusions of treatment effects should be based on controlled trials and not on observational studies. Nevertheless, based on the correlation between serum vitamin D level and infections, Ginde et al1 proposed that vitamin D supplementation may reduce the incidence of upper respiratory tract infections.
Nutrition is associated with a wide range of lifestyle variables, and there is a great risk of residual confounding caused by inadequate adjustments for complex social and environmental exposures acting over a persons life.2 Residual confounding may explain, for example, the divergent findings in observational studies and controlled trials on vitamin E.2 Therefore, great caution should be exercised when interpreting correlations between serum vitamin D levels and health outcomes.
Furthermore, certain randomized controlled trials on multivitamin supplements are relevant when considering the effect of vitamin D supplementation on respiratory tract infections. If a multivitamin supplement has . . . [Full Text of this Article] AUTHOR INFORMATION
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Association Between Serum 25-Hydroxyvitamin D Level and Upper Respiratory Tract Infection in the Third National Health and Nutrition Examination Survey
Adit A. Ginde, Jonathan M. Mansbach, and Carlos A. Camargo, Jr
Arch Intern Med. 2009;169(4):384-390.
ABSTRACT
| FULL TEXT
RELATED LETTER
Vitamin D Level, Respiratory Tract Infections, and Controlled Trials—Reply
Adit A. Ginde, Jonathan M. Mansbach, and Carlos A. Camargo, Jr
Arch Intern Med. 2009;169(15):1443-1444.
EXTRACT
| FULL TEXT
|